Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal
School of Health Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland, Sion, Switzerland.
BMJ Open. 2021 Jul 14;11(7):e052755. doi: 10.1136/bmjopen-2021-052755.
The present study analysed 4 years of a hospital register (2015-2018) to determine the risk of 30-day hospital readmission associated with the medical conditions and drug regimens of polymedicated, older inpatients discharged home.
Registry-based cohort study.
Valais Hospital-a public general hospital centre in the French-speaking part of Switzerland.
We explored the electronic records of 20 422 inpatient stays by polymedicated, home-dwelling older adults held in the hospital's patient register. We identified 13 802 hospital readmissions involving 8878 separate patients over 64 years old.
Sociodemographic characteristics, medical conditions and drug regimen data associated with risk of readmission within 30 days of discharge.
The overall 30-day hospital readmission rate was 7.8%. Adjusted multivariate analyses revealed increased risk of hospital readmission for patients with longer hospital length of stay (OR=1.014 per additional day; 95% CI 1.006 to 1.021), impaired mobility (OR=1.218; 95% CI 1.039 to 1.427), multimorbidity (OR=1.419 per additional International Classification of Diseases, 10th Revision condition; 95% CI 1.282 to 1.572), tumorous disease (OR=2.538; 95% CI 2.089 to 3.082), polypharmacy (OR=1.043 per additional drug prescribed; 95% CI 1.028 to 1.058), and certain specific drugs, including antiemetics and antinauseants (OR=3.216 per additional drug unit taken; 95% CI 1.842 to 5.617), antihypertensives (OR=1.771; 95% CI 1.287 to 2.438), drugs for functional gastrointestinal disorders (OR=1.424; 95% CI 1.166 to 1.739), systemic hormonal preparations (OR=1.207; 95% CI 1.052 to 1.385) and vitamins (OR=1.201; 95% CI 1.049 to 1.374), as well as concurrent use of beta-blocking agents and drugs for acid-related disorders (OR=1.367; 95% CI 1.046 to 1.788).
Thirty-day hospital readmission risk was associated with longer hospital length of stay, health disorders, polypharmacy and drug regimens. The drug regimen patterns increasing the risk of hospital readmission were very heterogeneous. Further research is needed to explore hospital readmissions caused solely by specific drugs and drug-drug interactions.
本研究分析了 4 年的医院登记数据(2015-2018 年),以确定与出院后居家的多药治疗老年住院患者的医疗状况和药物方案相关的 30 天内再次住院的风险。
基于登记的队列研究。
瑞士法语区瓦莱州的一家公立综合医院中心-Valais 医院。
我们研究了该医院患者登记处中 20422 名多药治疗、居家的老年住院患者的电子记录。我们确定了 30 天内涉及 8878 名单独患者的 13802 例住院再入院。
与出院后 30 天内再次住院风险相关的社会人口统计学特征、医疗状况和药物方案数据。
总体 30 天内医院再入院率为 7.8%。调整后的多变量分析显示,住院时间较长(每增加一天,OR=1.014;95%CI 1.006 至 1.021)、活动能力受损(OR=1.218;95%CI 1.039 至 1.427)、多种合并症(每增加一种国际疾病分类,第 10 次修订版疾病,OR=1.419;95%CI 1.282 至 1.572)、肿瘤疾病(OR=2.538;95%CI 2.089 至 3.082)、多药治疗(每增加一种处方药物,OR=1.043;95%CI 1.028 至 1.058)以及某些特定药物(包括止吐药和止吐药,每增加一个药物单位,OR=3.216;95%CI 1.842 至 5.617)、降压药(OR=1.771;95%CI 1.287 至 2.438)、功能性胃肠疾病药物(OR=1.424;95%CI 1.166 至 1.739)、全身激素制剂(OR=1.207;95%CI 1.052 至 1.385)和维生素(OR=1.201;95%CI 1.049 至 1.374),以及同时使用β受体阻滞剂和与酸相关疾病的药物(OR=1.367;95%CI 1.046 至 1.788),与 30 天内再次住院风险相关。
30 天内医院再入院风险与住院时间延长、健康状况、多药治疗和药物方案有关。增加医院再入院风险的药物方案模式非常多样化。需要进一步研究仅由特定药物和药物相互作用引起的医院再入院。